首页> 外文期刊>Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society >Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: Evaluation of 3,150 warming cycles
【24h】

Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: Evaluation of 3,150 warming cycles

机译:冷冻保存程序中玻璃化的早期卵裂期和囊胚期胚胎的结果:3,150个升温周期的评估

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To assess the outcomes achieved after Cryotop vitrification of both early cleavage and blastocyst-stage embryos and to determine whether the embryo developmental stage and embryo quality as well as the origin of the embryos (ovum donation cycles, patients' own oocytes) and the endometrial preparation for the embryo transfer had any effect on the final outcome. Design: Observational study. Setting: Private university-affiliated IVF center. Patient(s): Women undergoing 3,150 warming cycles whose embryos were vitrified due to various reasons. Intervention(s): Vitrification by the Cryotop open device. Main Outcome Measure(s): Delivery rate (DR) per warming cycle. Result(s): Survival rate was 95% (5,722 out of 6,019 embryos). The percentage of intact embryos at warming showing 100% blastomere survival was 93% (95% CI 90.1%-95.3%) for day 2 and 95% (95% CI 94.3%-95.7%) for day 3; 3,057 embryo transfers were performed (3% cancellation rate). The DR/warming cycle was 32.5% (95% CI 30.9%-34.2%). Slight differences in survival rate were found [94.9% (95% CI 93.0%-96.8%) for day 2, 94.2% (95% CI 93.4%-94.9%) for day 3, 95.7% (95% CI 94.5%-96.9%) for day 5, and 97.6% (95% CI 96.9%-98.6%) for day 6]. Overall implantation, clinical pregnancy, ongoing pregnancy, and live birth rates per warming cycle were 35.5% (95% CI 33.5%-38.5%), 41.7% (95% CI 39.9%-43.4%), 32.6% (95% CI 31.0%-34.2%), and 38.1% (95% CI 36.4%-39.8%) respectively. The linear regression model considering embryo developmental stage, ovum donation or patient's own oocytes, and hormonal replacement therapy or natural cycle for endometrial preparation (odds ratio 1.179; 95% CI 0.912-1.277) showed no impact on the DR. Conclusion(s): Highly successful cryopreservation of all embryo developmental stages is possible with the use of the Cryotop system. There are no variables clearly exerting a negative effect on the survival and delivery rates.
机译:目的:评估冷冻切割早期卵裂和胚泡期胚胎玻璃化后所取得的成果,并确定胚胎的发育阶段和胚胎质量以及胚胎的起源(卵子捐赠周期,患者自己的卵母细胞)以及胚胎的发育。子宫内膜的胚胎移植准备对最终结果没有任何影响。设计:观察性研究。地点:私立大学附属试管婴儿中心。患者:经过3,150个加温周期的妇女,由于各种原因,其胚胎已玻璃化。干预措施:Cryotop开放式设备进行玻璃化。主要指标:每个加温周期的输送量(DR)。结果:存活率为95%(6,019个胚胎中有5,722个)。在第2天,显示100%卵裂球存活率的完整胚胎百分比在第2天为93%(95%CI 90.1%-95.3%),在第3天为95%(95%CI 94.3%-95.7%);进行了3057次胚胎移植(取消率3%)。 DR /升温周期为32.5%(95%CI 30.9%-34.2%)。发现存活率略有差异[第2天为94.9%(95%CI 93.0%-96.8%),第3天为94.2%(95%CI 93.4%-94.9%),95.7%(95%CI 94.5%-96.9)第5天的百分比)和97.6%(第6天的95%CI 96.9%-98.6%)。每个加热周期的总体植入,临床妊娠,持续妊娠和活产率分别为35.5%(95%CI 33.5%-38.5%),41.7%(95%CI 39.9%-43.4%),32.6%(95%CI 31.0) %-34.2%)和38.1%(95%CI 36.4%-39.8%)。考虑胚胎发育阶段,捐卵或患者自己的卵母细胞以及激素替代疗法或子宫内膜制备的自然周期的线性回归模型(赔率为1.179; 95%CI为0.912-1.277)对DR没有影响。结论:使用Cryotop系统可以高度成功地冷冻保存所有胚胎发育阶段。没有任何变量显然会对生存率和分娩率产生负面影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号